Your Location:
Home >
Browse articles >
Jianpi Xiaoai Prescription Ameliorates Chemotherapy Resistance in Colon Cancer by Targeting FGF2 to Inhibit PI3K/Akt Signaling Pathway
Jianpi Xiaoai Prescription Ameliorates Chemotherapy Resistance in Colon Cancer by Targeting FGF2 to Inhibit PI3K/Akt Signaling Pathway
Enhanced Publication- Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 6, Pages: 120-130(2026)
DOI: 10.13422/j.cnki.syfjx.20251123
Revised:2025-03-17 ,
Accepted:18 March 2025
Scan QR Code
Full Text(HTML)
Figs( 5 ) Tabs( 9 )
References
Publication Info
Metrics
240
Views
180
Downloads
1
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Effect of Jianpi Xiaoai Prescription on Expression of Metastasis-related Factors in Tumor Microenvironment of Nude Mouse Model of Liver Metastasis of Colon Cancer
Effect of Jianpi Xiao' ai Prescription on Akt/mTOR Signaling Pathways in Colorectal Cells
Chinese Medicine in Treatment of Colorectal Cancer by Regulating Hedgehog Signaling Pathway: A Review
Mechanisms of Zuojinwan in Inhibiting Tumor-associated Macrophage M2 Polarization Against Colorectal Cancer Through Regulation of TIPE1/PI3K/Akt Signaling Pathway
Research Progress of Traditional Chinese Medicine in Improving Diabetic Retinopathy Based on Nrf2 Signaling Pathway
Related Author
HE Weihua
DENG Lan
JIANG Yilan
Xiao-lan JIAN
Pu-hua ZENG
Yong-min LI
Xiao-ning TAN
Feng-jiao HE
Related Institution
Wuhan Hospital of Traditional Chinese Medicine
Affiliated Hospital of Jiangxi University of Chinese Medicine
Affiliated Hospital of Hunan Academy of Chinese Medicine
Innovative Platform of Anti-tumor Chinese Drugs, Hunan Key Laboratory of Chinese Medicine Oncology, The Affiliated Hospital of Hunan Academy of Chinese Medicine
Henan University of Chinese Medicine


